Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
94,9 EUR | +1,32% | +4,08% | +1,78% |
24/04 | Citadel Advisors avvia short su STMicroelectronics | AN |
23/04 | Ridotto uno short su DiaSorin, aumentato su STM | AN |
Attività
A fine 2023 il gruppo dispone di 10 siti di produzione con sede in Italia, Stati Uniti (6), Canada, Germania e Regno Unito.
Numero di dipendenti: 3 209
Vendite per attività
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Diagnostic Kits
100,0
%
| 1 361 | 100,0 % | 1 148 | 100,0 % | -15,64% |
Vendite per regione
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
North America
52,9
%
| 783 | 57,5 % | 607 | 52,9 % | -22,41% |
Europe
23,1
%
| 269 | 19,8 % | 265 | 23,1 % | -1,53% |
Italy
15,1
%
| 198 | 14,5 % | 174 | 15,1 % | -12,14% |
Rest of the World
8,9
%
| 112 | 8,2 % | 102 | 8,9 % | -8,48% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Carlo Rosa
CEO | Chief Executive Officer | 58 | 01/01/98 |
Director of Finance/CFO | 53 | 01/01/11 | |
Director/Board Member | 61 | 01/01/00 | |
Riccardo Fava
IRC | Investor Relations Contact | - | - |
Stefano Ronchi
HRO | Human Resources Officer | 64 | 01/01/07 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 65 | 29/04/22 | |
Carlo Rosa
CEO | Chief Executive Officer | 58 | 01/01/98 |
Director/Board Member | 61 | 01/01/00 | |
Franco Moscetti
BRD | Director/Board Member | 72 | 26/03/07 |
Diego Pistone
BRD | Director/Board Member | 73 | 29/04/22 |
Luca Melindo
BRD | Director/Board Member | 53 | 24/04/19 |
Monica Tardivo
BRD | Director/Board Member | 54 | 28/04/16 |
Roberta Somati
BRD | Director/Board Member | 55 | 22/04/13 |
Stefano Altara
BRD | Director/Board Member | 56 | 23/04/14 |
Director/Board Member | 64 | 28/04/16 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 55 948 257 | 21 096 460 ( 37,71 %) | 2 588 278 ( 4,626 %) | 37,71 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
DIASORIN S.P.A. 4.86% | 2 716 663 | 4.86% | 262 592 646 $ |
IMPEDIMED LIMITED 0.66% | 13 300 000 | 0.66% | 798 266 $ |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Luminex Molecular Diagnostics, Inc.
Luminex Molecular Diagnostics, Inc. Medical/Nursing ServicesHealth Services Luminex Molecular Diagnostics, Inc. develops DNA based diagnostics tests and software solutions, which include genetic tests for disorders, drug metabolism and infectious diseases. The firm’s products include P450-2D6, P450-2C9, P450-2C19, AJ panel and CFTR. The company was founded in March 2007 and is headquartered in Toronto, Canada. |
Medical/Nursing Services
|
Diasorin, Inc.
Diasorin, Inc. Medical SpecialtiesHealth Technology Diasorin, Inc. develops and manufactures reagents for in vitro diagnostics. It has products in the fields of infectious disease, hepatitis, endocrinology, bone and mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The company was founded in 1975 and is headquartered in Stillwater, MN. |
Medical Specialties
|
Diasorin Italia SpA
Diasorin Italia SpA Medical/Nursing ServicesHealth Services Part of DiaSorin SpA, Diasorin Italia SpA is a diagnostic specialist that develops, produces, and globally markets reagent kits for in vitro diagnostics. Diasorin Italia is based in Saluggia, Italy. The Italian company continues to invest in research and development, leveraging its expertise in immunodiagnostics to deliver high-quality assays and improve laboratory efficiency. Ugo Gay has been the CEO of the private company since 2000. |
Medical/Nursing Services
|
Settore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+1,78% | 5,41 Mrd | |
+0,89% | 12,8 Mrd | |
-10,29% | 7,61 Mrd | |
-1,16% | 4,51 Mrd | |
+5,74% | 4,49 Mrd | |
-50,70% | 3,29 Mrd | |
+12,21% | 2,73 Mrd | |
-16,13% | 2,02 Mrd | |
-11,50% | 1,73 Mrd | |
-5,02% | 1,64 Mrd |
- Borsa valori
- Azioni
- Azione DIA
- Società DiaSorin S.p.A.